IL6 and lung disorder: The high rates of cardiovascular disease, pulmonary disease, older age, elevated IL-6 and D-dimer levels that we observed in our cohorts (Tables 1–2) are common features in COVID-19 patients, and are potential predictors of mortality within the wider NYC cohort [34] and elsewhere [44–46, 53, 55].